Occuity Launches New Crowdfunding Round on Crowdcube
- Richard Kadri-Langford

- Sep 3, 2025
- 2 min read
Updated: Sep 4, 2025
We’re pleased to announce that Occuity has today launched a new crowdfunding campaign on leading platform Crowdcube.

This gives people who believe in our mission — but who are not high-net-worth or sophisticated investors, or who would prefer to invest less than £10,000 — the opportunity to join us on our journey. With a minimum investment of just £30, this is an exciting opportunity to become an equity shareholder in a fast-growing British MedTech company with global ambitions.
Why Now?
Since our last investment round, Occuity has made significant progress:
Revenue generating: our first product, the PM1 Pachymeter, is now on the market.
AX1 Axiometer™ launching next year: targeting the rapidly growing myopia management market, this represents a much larger commercial opportunity.
Patented technology: Occuity now holds 15 Patents (14 Granted), protecting our unique optical innovations.
Strong pipeline: we are developing a range of disruptive products in diabetes and Alzheimer’s screening, with the potential to transform healthcare globally.
Why Early Access Matters
What’s Early Access?
Occuity will be live on Crowdcube very soon, but pre-registering today gives you exclusive benefits:
Front of the queue With limited numbers of shares or tax relief available, late investors can miss out. Early Access ensures you’re first to know the moment the opportunity is live.
Stay in the loop
Receive regular updates directly from us before the campaign goes live, helping you make an informed investment decision as early as possible.
👉 Register now for Early Access: www.crowdcube.com/early-access/occuity
Join Us on Our Mission
Occuity is building revolutionary, non-invasive optical technology to transform the way we screen and monitor diseases such as myopia, diabetes, and Alzheimer’s — all through a simple, pain-free scan of the eye.
By investing, you’re not only supporting the growth of a cutting-edge British MedTech company, but you’re also helping us realise our mission to improve the lives of millions around the world.
👉 Register now for Early Access: www.crowdcube.com/early-access/occuity
Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.


Comments